• Home
  • Contacts
  • FAQs
  • Careers
    • Clinical Research Associate II Orthopedic & Spine

Mesoblast

  • About us
    • Company overview
    • Board of Directors
    • Corporate Governance
    • Partners
  • Products
    • Cardiovascular diseases
    • Diabetes
    • Oncology
    • Eye disease products
    • Orthopedic Diseases
  • Technology
    • Overview
    • Scientific publications
      • Technology
      • Orthopedic
      • Cardiovascular
      • Neurological
  • Clinical trials
    • Overview
    • FAQs
  • Investors
    • Overview
    • Market announcements
    • Presentations
    • Analyst Coverage
    • Webcasts
    • Annual Reports
    • ADR trading
    • Email alerts
    • Shareholder meetings
  • Newsroom
    • Market Announcements
      • Archives
    • Image downloads
    • Email alerts
    • Contacts

Presentations

  • 27 February 2012 – Half Year Results

  • 11 January 2012 – Presentation to 30th Annual JP Morgan Healthcare Conference in USA

  • 24 November 2011 - Chief Executive Presentation to AGM

  • 14 November 2011 – Presentation to the American Heart Association by Dr Emerson C. Perin, Texas Heart Institute

  • 9 November 2011 – Credit Suisse Healthcare Conference, Phoenix, Arizona

  • 24 August 2011 – Webcast of Conference Call on 2011 Preliminary Financial Results
    http://www.brr.com.au/event/frame/85380

  • 24 August 2011 - Mesoblast Management Presentation

  • 14 June 2011 Presentation to 8th Nomura Asia Equity Forum, Singapore

  • 9 February 2011 CEO Presentation to EGM

  • 29 November, 2010 Shareholder Annual General Meeting (AGM)

  • 14 November 2010 Nomura US Asia Corporation Day

  • 22 September 2010 CEO Presentation to EGM

  • 30 November 2009 Executive Director’s Presentation to the 2009 Annual General Meeting

  • 25 June 2009 Investor Presentation to Australian Institutional Investors and Fund Managers. Executive Director Professor Silviu Itescu

  • Investors
    • Overview
    • Market announcements
    • Presentations
    • Analyst Coverage
    • Webcasts
    • Annual Reports
    • ADR trading
    • Email alerts
    • Shareholder meetings

    Products

    The American Heart Association estimates 80 million American adults (approximately 1 in 3) have one or more forms of cardiovascular diseases...

    Find out more

    Technology

    Stem cell therapy is emerging as the new paradigm for treating and potentially curing human disease. It involves the use of living cells...

    Find out more

    Clinical trials

    Mesoblast is aiming to produce therapeutics for the treatment of heart conditions, blood vessel diseases of the eyes and legs bone marrow regeneration after cancer...

    Find out more
    • Privacy policy
    • Disclaimer
    • Webmail
    • Sitemap
    Copyright © 2012 Mesoblast | Website design by Mightymedia